Table 4 Expression of luminal and basal markers in triple negative low proliferation (TNLP) tumors.

From: Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers

Morphology

NA for staining (not on TMA)

Available for staining (TMA)

AR positive

INPP4B positive

Nestin positive

SOX10 positive

Adenoid cystic (n = 3)

2

1

0

0

1

1

Atypical MGA-like (n = 1)

0

1

1

1

1

1

CA-apocrine features (n = 14)

7

7

7

7

0

0

Apocrine (IDC) (n = 30)

7

23

22

23

0

1

Apocrine (ILC) (n = 3)

0

3

3

3

0

0

Apocrine (Mixed) (n = 2)

1

1

1

1

0

0

Histiocytoid (IDC) (n = 1)

0

1

1

1

0

0

Histiocytoid (ILC) (n = 4)

0

4

4

1

0

0

LG adenosquamous (n = 3)

0

3

0

3

3

3

Micropapillary mucinous (n = 1)

1

0

NA

NA

NA

NA

No special type (n = 7)

1

6

1

2

5

5

Squamous (n = 1)

1

0

NA

NA

NA

NA

Total (n = 70)

20

50

40

42

10

11

  1. NA not available, MGA microglandular adenosis, TMA tissue microarray, AR androgen receptor, CA carcinoma, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, LG low grade.